##  [China NMPA Launches Online Platform for Non-Clinical Drug Safety Evaluation Institutions](/index%2ephp/mandate/china-nmpa-launches-online-platform-for-non-clinical-drug-safety-evaluation-institutions) 

October 16, 2025

**China NMPA Launches Online Platform for Non-Clinical Drug Safety Evaluation Institutions**   
**October 16, 2025**

The **National Medical Products Administration (NMPA)** has introduced an **online registration platform** via its **Government Service Portal (ZWFW)** for **non-clinical drug safety evaluation research institutions (GLP labs)**.

This initiative aims to **digitize and streamline oversight** of institutions performing pre-clinical safety studies, ensuring compliance and transparency in supporting **drug development and registration**.

**Key Highlights:**

- **Digital Platform Launch:** Labs can register, update, and verify information online.
- **Scope:** Applicable to **profit-making legal entities** conducting non-clinical safety research.
- **Application Process:** **Fee-free**, fully online, with **immediate confirmation** upon submission.
- **Support & Consultation:** Dedicated hotlines for business and technical guidance.

**Purpose:**   
Enhances **regulatory transparency, data traceability, and compliance oversight** for laboratories performing non-clinical safety evaluations critical for pre-clinical drug research.



[Consult Now](/webform/consult?url=https://preprod.freyrsolutions.com/index%2ephp/mandate/china-nmpa-launches-online-platform-for-non-clinical-drug-safety-evaluation-institutions)



Source

<https://zwfw.nmpa.gov.cn/web/index>

 

 

Select Mandate HA

[NMPA](/index%2ephp/mandate-by-ha/nmpa)

 

Select Mandate Function

[Country Regulatory Affairs](/index%2ephp/mandate-by-function/country-regulatory-affairs)